Editorial: Innovative approaches to treatment - Refractory depression: The ketamine story

Indian Journal of Psychiatry

Volumn 52, Issue 2, 2010, Pages 97-99

  Sathyanarayana Rao, T S ^a   Andrade, Chittaranjan ^b  

^a JSS MEDICAL COLLEGE   (India)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BENZODIAZEPINE; GLUTAMINE; KAINIC ACID RECEPTOR; KETAMINE; N METHYL DEXTRO ASPARTIC ACID; PLACEBO; PROPOFOL; TIANEPTINE; TRAXOPRODIL;

ALCOHOLISM; BLOOD PRESSURE; CHIRALITY; CLINICAL TRIAL; CONFUSION; DEPRESSION; DIZZINESS; DRUG DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EDITORIAL; ELECTROCONVULSIVE THERAPY; EUPHORIA; EXPERIMENTAL THERAPY; HUMAN; LIBIDO; MAJOR DEPRESSION; MORBIDITY; NEUROTRANSMISSION; NONHUMAN; PERCEPTION DISORDER; REMISSION; SIDE EFFECT; SUICIDE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 77954461658     PISSN: 00195545     EISSN: 19983794     Source Type: Journal    
DOI: 10.4103/0019-5545.64573     Document Type: Editorial

References (20)

1. Andrade C. Psychopharmacology. In: Bhugra D, Ranjith G, Patel V, editors. Handbook of Psychiatry: A South Asian Perspective. 2nd ed. New Delhi: Byword Publishers; 2010.
2. Tardito D, Perez J, Tiraboschi E, Musazzi L, Racagni G, Popoli M. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressant: A critical overview. Pharmacol Rev 2006;58:115-134
3. Pittenger C, Duman RS. Stress, depression, and neuroplasticity: A convergence of mechanisms. Neuropsychopharmacology 2008;33:88-109.
4. McEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P, et al.. The neurobiological properties of tianeptine (Stablon): From monoamine hypothesis to glutamatergic modulation. Mol Psychiatry 2010;15:237-249
5. Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 3rd ed. Cambridge: Cambridge University Press; 2008.
6. Hashimoto K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev 2009;61:105-123
7. Skolnick P, Popik P, Trullas R. Glutamate-based antidepressants: 20 years on. Trends Pharmacol Sci 2009;30:563-569
8. Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006;63:856-864
9. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000;47:351-354
10. Goforth HW, Holsinger T. Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy. J ECT 2007;23:23-25
11. Liebrenz M, Borgeat A, Leisinger R, Stohler R. Intravenous ketamine therapy in a patient with a treatment-resistant major depression. Swiss Med Wkly 2007;137:234-236
12. Price RB, Nock MK, Charney DS, Mathew SJ. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatmentresistant depression. Biol Psychiatry 2009;66:522-526
13. aan het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS, et al. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry 2010;67:139-145
14. Okamoto N, Nakai T, Sakamoto K, Nagafusa Y, Higuchi T, Nishikawa T. Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: Comparing ketamine and propofol anesthesia. J ECT 2009 in press.
15. Kohrs R, Durieux ME. Ketamine: Teaching an old drug new tricks. Anesth Analg 1998;87:1186-1193
16. Raeder JC, Stenseth LB. Ketamine: A new look at an old drug. Curr Opin Anaesthesiol 2000;13:463-468
17. Liu J, Ji XQ, Zhu XZ. Comparison of psychic emergence reactions after (+/-)-ketamine and (+)-ketamine in mice. Life Sci 2006;78:1839-1844
18. Paul R, Schaaff N, Padberg F, Möller HJ, Frodl T. Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: Report of two cases. World J Biol Psychiatry 2009;10:241-244
19. Machado-Vieira R, Yuan P, Brutsche N, DiazGranados N, Luckenbaugh D, Manji HK, et al. Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist. J Clin Psychiatry 2009;70:1662-1666
20. Machado-Vieira R, Salvadore G, Diazgranados N, Zarate CA Jr. Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacol Ther 2009;123:143-150